140 related articles for article (PubMed ID: 3028608)
1. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.
Rettig WJ; Spengler BA; Chesa PG; Old LJ; Biedler JL
Cancer Res; 1987 Mar; 47(5):1383-9. PubMed ID: 3028608
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
4. Analysis of nerve growth factor receptor expression in human neuroblastoma and neuroepithelioma cell lines.
Baker DL; Reddy UR; Pleasure D; Thorpe CL; Evans AE; Cohen PS; Ross AH
Cancer Res; 1989 Aug; 49(15):4142-6. PubMed ID: 2545334
[TBL] [Abstract][Full Text] [Related]
5. Human neuroblastoma I-type cells are malignant neural crest stem cells.
Ross RA; Spengler BA; Domènech C; Porubcin M; Rettig WJ; Biedler JL
Cell Growth Differ; 1995 Apr; 6(4):449-56. PubMed ID: 7794812
[TBL] [Abstract][Full Text] [Related]
6. NUB-7: a stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages.
Dimitroulakos J; Squire J; Pawlin G; Yeger H
Cell Growth Differ; 1994 Apr; 5(4):373-84. PubMed ID: 8043511
[TBL] [Abstract][Full Text] [Related]
7. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
8. Coordinate morphological and biochemical interconversion of human neuroblastoma cells.
Ross RA; Spengler BA; Biedler JL
J Natl Cancer Inst; 1983 Oct; 71(4):741-7. PubMed ID: 6137586
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or nonneuronal (S) neural crest cells.
Ross RA; Spengler BA; Rettig WJ; Biedler JL
Prog Clin Biol Res; 1994; 385():253-9. PubMed ID: 7972217
[No Abstract] [Full Text] [Related]
10. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.
Ciccarone V; Spengler BA; Meyers MB; Biedler JL; Ross RA
Cancer Res; 1989 Jan; 49(1):219-25. PubMed ID: 2535691
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
Rettig WJ; Chesa PG; Beresford HR; Feickert HJ; Jennings MT; Cohen J; Oettgen HF; Old LJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6406-12. PubMed ID: 2877731
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells.
Ross RA; Hein AM; Braca JA; Spengler BA; Biedler JL; Scammell JG
Oncol Res; 2002; 13(2):87-94. PubMed ID: 12392156
[TBL] [Abstract][Full Text] [Related]
13. Morphologic conversion of a neuroblastoma-derived cell line by E6-mediated p53 degradation.
Gaitonde SV; Qi W; Falsey RR; Sidell N; Martinez JD
Cell Growth Differ; 2001 Jan; 12(1):19-27. PubMed ID: 11205742
[TBL] [Abstract][Full Text] [Related]
14. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
15. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas.
Gestblom C; Hoehner JC; Hedborg F; Sandstedt B; Påhlman S
Am J Pathol; 1997 Jan; 150(1):107-17. PubMed ID: 9006328
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines.
Rogers SL; Cutts JL; Gegick PJ; McGuire PG; Rosenberger C; Krisinski S
Exp Cell Res; 1994 Apr; 211(2):252-62. PubMed ID: 8143771
[TBL] [Abstract][Full Text] [Related]
17. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
[TBL] [Abstract][Full Text] [Related]
18. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
Matsumura T; Sugimoto T; Sawada T; Amagai T; Negoro S; Kemshead JT
Cancer Res; 1987 Jun; 47(11):2924-30. PubMed ID: 3567910
[TBL] [Abstract][Full Text] [Related]
19. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
20. Differential collagen biosynthesis by human neuroblastoma cell variants.
DeClerck YA; Bomann ET; Spengler BA; Biedler JL
Cancer Res; 1987 Dec; 47(24 Pt 1):6505-10. PubMed ID: 2445473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]